Research and Development

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …

Indian contract research and manufacturing services company Jubilant Organosys shrugged off the effects of the economic downturn with a buoyant …

With increased investment in R&D largely failing to fill drug development pipelines, the pharma industry is looking to get more …

Merck has continued the trend of big pharma companies signing on the dotted line with small biotech outfits in a …

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …

Inadequate production capacity means that the poorest countries in the world will be denied access to vaccines for H1N1 influenza, …

A new 'Blueprint' to put innovation at the heart of the NHS and help support the UK life sciences sector …

Charles River Laboratories has unveiled a major shake-up its business and sales activities as part of a reorganisation prompted by …